GGrantIndex
Sort

64,565 grants matching drug discovery

15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi

$507,599
Li Li · Case Western Reserve University · U01 · FY2017 · CA

Vanderbilt Network Lead Academic Participating Site for the NCTN

$507,576
Jordan D Berlin · Vanderbilt University Medical Center · UG1 · FY2022 · CA

Project 2: Targeting differentiation-linked redox sensitivity in melanoma

$507,564
Thomas G Graeber · University Of California Los Angeles · P01 · FY2023 · CA

Project 2: Targeting differentiation-linked redox sensitivity in melanoma

$507,564
Thomas G Graeber · University Of California Los Angeles · P01 · FY2022 · CA

Developing Ubiquitin Ligase Agonists as Cancer Therapeutics

$507,502
Bruce E Clurman · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA

Systems Genetics of Vascular Smooth Muscle Phenotypes

$507,435
Mete Civelek · University Of Virginia · R01 · FY2023 · HL

Molecular Genetics of HSV DNA Polymerase Gene

$507,375
Donald M Coen · Harvard Medical School · R01 · FY2011 · AI

Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati

$507,293
Christian C Melander · North Carolina State University Raleigh · R01 · FY2017 · AI

CNV And Stroke (CaNVAS)

$507,267
John W. Cole · University Of Maryland Baltimore · R01 · FY2022 · NS

Development of Angiogenesis Inhibitors

$507,254
William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA

Genetics and Molecular Mechanisms of Prostate Cancer

$507,254
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

STRESS INDUCTION OF GLUCOSE REGULATED PROTEIN GRP78/BiP

$507,253
Amy S Lee · University Of Southern California · R01 · FY2009 · CA

Homologous Chromosome Pairing in Meiosis

$507,239
Sean M Burgess · University Of California At Davis · R01 · FY2019 · GM

Molecular Analysis of Modular Polyketide Synthases

$507,173
David H Sherman · University Of Michigan At Ann Arbor · R01 · FY2011 · GM

The DNA Packaging Motor of Bacteriophage phi29

$507,171
Paul James Jardine · University Of Minnesota · R01 · FY2022 · GM

Molecular and genetic studies of NMNAT2 in neuroprotection

$507,169
Hui-Chen Lu · Trustees Of Indiana University · R01 · FY2024 · NS

Training in Pharmacological Sciences

$507,167
Joey V Barnett · Vanderbilt University · T32 · FY2016 · GM

A Combined Approach to Targeted Antiherpesvirus Drugs

$507,164
Harvard University (Medical School) · R01 · FY2004 · AI

DEVELOPMENTAL FUNDS

$507,158
Michelle M Le Beau · University Of Chicago · P30 · FY2010 · CA

Unified Program for Therapeutics in Children (UPTiC)

$507,132
Kanecia Obie Zimmerman · Duke University · T32 · FY2021 · HD

CHARMM Development for Performance, Big-Data Accessibility and Usability

$507,121
Charles L Brooks · University Of Michigan At Ann Arbor · R01 · FY2017 · GM

RNA homodimerization strand displacement pathways to extended duplexes: Atomistic details for a mechanistic paradigm to identify unique antiviral targets for current and emerging viral pandemics

$507,121
Jeffrey D Evanseck · Duquesne University · R15 · FY2025 · AI

CAREER: A CMOS Multi-Modality Cellular Interfacing Platform for Drug Screening and Stem Cell Culture

$507,100
Hua Wang · Georgia Tech Research Corporation · · FY2015 · ENG

Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis

$507,004
Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2024 · CA

Regulation of chemokine receptor signaling

$507,000
Adriano Marchese · Medical College Of Wisconsin · R35 · FY2025 · GM